GlassScriptPhysician profile
Craig Rezac
NPI 1730258294
$32,731.90
in general payments reported to CMS, 2019-2025
20 companies · $870 in 2025
The $870 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,545 · 2020: $2,466 · 2021: $2,496 · 2022: $552 · 2023: $18K · 2024: $6,582 · 2025: $870.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Food and Beverage: $2,502 · Travel and Lodging: $1,906 · Education: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $21,125.00 |
| Food and Beverage | $2,501.65 |
| Travel and Lodging | $1,905.86 |
| Education | $140.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $25,466.74 | 2019-2025 | Da Vinci Surgical System |
| Abbvie INC. | $2,581.51 | 2023 | |
| Thd America, INC. | $2,275.23 | 2019-2025 | |
| Ethicon US, LLC | $1,193.06 | 2020-2025 | Echelon Flex, Stratafix, Surgicel Nu-Knit |
| Allergan, INC. | $365.87 | 2019-2022 | |
| Boston Scientific Corporation | $231.27 | 2023-2025 | Therasphere Y90 Glass Microspheres 10 Gbq, Axios |
| Davol INC. | $147.43 | 2021 | |
| Applied Medical Resources Corporation | $66.98 | 2019 | |
| Axonics, INC. | $59.44 | 2024 | Axonics |
| W. L. Gore & Associates, INC. | $59.36 | 2020 | |
| Shire North American Group INC | $42.83 | 2019 | |
| Innovation Technologies INC | $41.95 | 2021 | |
| Smith+Nephew, INC. | $40.78 | 2019-2020 | |
| Medtronic, INC. | $39.98 | 2024 | Valleylab Ft10 |
| Braintree Laboratories, INC. | $27.43 | 2019-2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $22.67 | 2022 | |
| Novum Pharma, LLC | $20.21 | 2019 | |
| Ferring Pharmaceuticals INC. | $19.69 | 2019 | |
| Covidien LP | $14.83 | 2019 | |
| Merck Sharp & Dohme LLC | $14.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Rezac listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.